Drug interactions modulate the potential for evolution of resistance
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Antimicrobial treatments increasingly rely on multidrug combinations, in part because of the emergence and spread of antibiotic resistance. The continued effectiveness of combination treatments depends crucially on the frequency with which multidrug resistance arises. Yet, it is unknown how this propensity for resistance depends on cross-resistance and on epistatic interactions—ranging from synergy to antagonism—between the drugs. Here, we analyzed how interactions between pairs of drugs affect the spontaneous emergence of resistance in the medically important pathogen Staphylococcus aureus . Resistance is selected for within a window of drug concentrations high enough to inhibit wild-type growth but low enough for some resistant mutants to grow. Introducing an experimental method for high-throughput colony imaging, we counted resistant colonies arising across a two-dimensional matrix of drug concentrations for each of three drug pairs. Our data show that these different drug combinations have significantly different impacts on the size of the window of drug concentrations where resistance is selected for. We framed these results in a mathematical model in which the frequencies of resistance to single drugs, cross-resistance, and epistasis combine to determine the propensity for multidrug resistance. The theory suggests that drug pairs which interact synergistically, preferred for their immediate efficacy, may in fact favor the future evolution of resistance. This framework reveals the central role of drug epistasis in the evolution of resistance and points to new strategies for combating the emergence of drug-resistant bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952
Self-citationTHE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Principles for the Buffering of Genetic Variation
Hartman IV, J. L. (2001) · Science · doi:10.1126/science.291.5506.1001 · Cited by 808
Principles for the buffering of genetic variation
Hartman, J. L., Garvik, B., & Hartwell, L. (2001) · Science · doi:10.1126/science.1056072 · Cited by 808
Pharmacodynamics: Relation to Antimicrobial Resistance
Rybak, M. J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.04.001 · Cited by 120
Cited by
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
Toprak, E., Veres, A., Michel, J.-B., Chait, R., Hartl, D. L., & Kishony, R. (2012) · Nature Genetics · doi:10.1038/ng.1034 · Cited by 764
“In such experiments, bacterial populations are typically exposed to fixed drug concentrations that are chosen to be high enough to partially or completely inhibit growth of the base strain, thus imposing a selective advantage for resistant mutants, yet low enough for some spontaneously occurring resistant mutants to s…”
BackgroundSelf-citationMultidrug evolutionary strategies to reverse antibiotic resistance
Baym, M., Stone, L. K., & Kishony, R. (2016) · Science · doi:10.1126/science.aad3292 · Cited by 710
Self-citationMalaria biology and disease pathogenesis: insights for new treatments
Miller, L. H., Ackerman, H. C., Su, X.-Z., & Wellems, T. E. (2013) · Nature Medicine · doi:10.1038/nm.3073 · Cited by 582
Metal Resistance and Its Association With Antibiotic Resistance
Pal, C., Asiani, K., Arya, S., Rensing, C., Stekel, D. J., Larsson, D. G. J., & Hobman, J. L. (2017) · Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2017.02.001 · Cited by 438
Droplet microfluidics for microbiology: techniques, applications and challenges
Kaminski, T. S., Scheler, O., & Garstecki, P. (2016) · Lab on a Chip · doi:10.1039/c6lc00367b · Cited by 424
Selective pressure of antibiotic pollution on bacteria of importance to public health
Tello, A., Austin, B., & Telfer, T. C. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104650 · Cited by 383
Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence
Rotem, E., Loinger, A., Ronin, I., Levin-Reisman, I., Gabay, C., Shoresh, N., Biham, O., & Balaban, N. Q. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004333107 · Cited by 355
Drug interactions and the evolution of antibiotic resistance
Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2133 · Cited by 350
“Recent studies have suggested that antagonistic drug pairs can slow down and potentially even reverse the evolution of drug resistanc”
Self-citationApplying evolutionary biology to address global challenges
Carroll, S. P., Jørgensen, P. S., Kinnison, M. T., Bergstrom, C. T., Denison, R. F., Gluckman, P., Smith, T. B., Strauss, S. Y., & Tabashnik, B. E. (2014) · Science · doi:10.1126/science.1245993 · Cited by 314
Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance
Palmer, A. C., & Kishony, R. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3351 · Cited by 285
Self-citationOz, T., Guvenek, A., Yildiz, S., Karaboga, E., Tamer, Y. T., Mumcuyan, N., Ozan, V. B., Senturk, G. H., Cokol, M., Yeh, P., et al. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu191 · Cited by 275
Self-citationAlternating antibiotic treatments constrain evolutionary paths to multidrug resistance
Kim, S., Lieberman, T. D., & Kishony, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409800111 · Cited by 264
Self-citationCombination therapies for combating antimicrobial resistance
Fischbach, M. A. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.003 · Cited by 259
Positive Epistasis Drives the Acquisition of Multidrug Resistance
Trindade, S., Sousa, A., Xavier, K. B., Dionisio, F., Ferreira, M. G., & Gordo, I. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000578 · Cited by 252
Nonoptimal microbial response to antibiotics underlies suppressive drug interactions
Bollenbach, T., Quan, S., Chait, R., & Kishony, R. (2009) · Cell · doi:10.1016/j.cell.2009.10.025 · Cited by 227
Self-citationCombination therapeutics in complex diseases
He, B., Lu, C., Zheng, G., He, X., Wang, M., Chen, G., Zhang, G., & Lu, A. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12930 · Cited by 112
Mapping Differentiation under Mixed Culture Conditions Reveals a Tunable Continuum of T Cell Fates
Antebi, Y. E., Reich-Zeliger, S., Hart, Y., Mayo, A., Eizenberg, I., Rimer, J., Putheti, P., Pe'er, D., & Friedman, N. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001616 · Cited by 100
“In order to gain better understanding of the logic employed by the GRN governing cell differentiation, it is beneficial to study its responses under mixed input conditions [2,20–25] at the single cell level.”
BackgroundGenetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations
Hill, J. A., Ammar, R., Torti, D., Nislow, C., & Cowen, L. E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003390 · Cited by 93
ScanLag: High-throughput Quantification of Colony Growth and Lag Time
Levin-Reisman, I., Fridman, O., & Balaban, N. Q. (2014) · Journal of Visualized Experiments · doi:10.3791/51456 · Cited by 64
Quantitative Measurements of Type I and Type II Persisters Using ScanLag
Levin-Reisman, I., & Balaban, N. Q. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2854-5_7 · Cited by 25
Metadata
- Authors
- Michel, J.-B., Yeh, P. J., Chait, R., Moellering, R. C., & Kishony, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-09-30
- Volume
- 105
- Issue
- 39
- Pages
- 14918-14923
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2034243251
- Cited by
- 215
- References
- 6
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.